Drug discovery: a combined approach (Accelerating Medicines Partnership)

drug pipeline 1 Minute

I’ve been struck repeatedly over the past decade by how dismal the pipeline looks for new drugs, particularly in the domain of brain diseases. Yesterday NIH and some of the biggest drug companies announced a new combined approach at the National Press Club, story here. This is a big project: $230M –even hefty when compared to EU standards. The lions share of the money will be spent on Alzheimer’s disease.

Published by jlolds

Native Angeleno, professor of Neuroscience and Public Policy at George Mason University

Published